Trials / Completed
CompletedNCT00529295
Titrated Oral Compared With Vaginal Misoprostol for Labor Induction at Term
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 220 (actual)
- Sponsor
- China Medical University Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to estimate the safety and efficacy of titrated oral misoprostol compared with vaginal route for labor induction at term.
Detailed description
Oral misoprostol absorption is more rapid and possible more predictable, with a peak serum concentration following oral administration of 34 minutes and a half-life of 20-40 minutes. Peak serum concentration for vaginal administration is 60-80 minutes, this level being sustained for up to four hours. Although the direct local effect of vaginal administration on cervical ripening may be advantageous, the shorter half-life of oral delivery may be beneficial in the event of uterine hyperstimulation.In order to avoid uterine hyperstimulation, it appears reasonable to suggest that oral misoprostol should be administered in small, frequent doses, titrated against the uterine response.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | misoprostol | Titrated oral misoprostol: one tablet of 200 microgram was dissolved in water 200 ml, and 20 ml P.O. per one hour for 4 doses, then titrated against uterine response; Vaginal misoprostol: 25 microgram per vagina |
Timeline
- Start date
- 2005-06-01
- Completion
- 2007-03-01
- First posted
- 2007-09-14
- Last updated
- 2007-09-14
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT00529295. Inclusion in this directory is not an endorsement.